What Is Selank?
Selank is a synthetic seven-amino-acid peptide with the sequence:
Thr-Lys-Pro-Arg-Pro-Gly-Pro
It was developed from research involving tuftsin, a naturally occurring immune-related peptide.
Tuftsin itself consists of:
Thr-Lys-Pro-Arg
Selank extends that sequence by adding:
Pro-Gly-Pro
This created a peptide researchers became interested in not only for immune biology, but particularly for:
anxiety + stress + neurotransmission + cognition + neuroimmune signaling.
Unlike many compounds in the research-peptide market, Selank does have published human clinical research.
But the clinical literature is still small, much of it comes from Russian research groups, and it has not undergone the kind of large multinational development program required for FDA approval in the United States.
Why Are Researchers Interested in Selank?
Selank became best known as an experimental:
anxiolytic
meaning a compound studied for its ability to reduce anxiety.
Researchers have compared it with benzodiazepine medications and have investigated possible effects involving:
- GABA signaling
- Anxiety
- Stress responses
- Emotional regulation
- Cognition
- Memory
- Neurotransmitter systems
- Enkephalins
- Gene expression
- Immune signaling
One human study included 62 patients with generalized anxiety disorder and neurasthenia.
Thirty received Selank and 32 received the benzodiazepine medazepam.
Researchers reported similar anxiolytic effects between the two groups, while Selank also showed antiasthenic and psychostimulant effects.
That is a legitimate human clinical signal.
It is also nowhere near enough by itself to establish Selank as equivalent to an FDA-approved anxiety medication.
How Might Selank Work?
There probably isn’t one single mechanism.
Research suggests Selank can influence several interconnected systems.
The most commonly discussed include:
GABA signaling + enkephalin metabolism + neurotransmitter-related gene expression + neuroimmune signaling.
This is important because the internet often simplifies Selank into:
“a peptide version of a benzodiazepine.”
That’s not really accurate.
Selank appears to interact with some of the same broad inhibitory brain systems, but it is chemically and pharmacologically very different.
What About GABA?
This is probably Selank’s most important mechanistic research area.
GABA stands for:
gamma-aminobutyric acid
and is the major inhibitory neurotransmitter in the adult brain.
In simplified terms, GABA helps prevent neural activity from becoming excessively excitable.
Benzodiazepines such as diazepam and alprazolam enhance signaling through GABA-A receptors.
Selank appears to affect the GABAergic system too—but not necessarily by acting like a classic benzodiazepine.
A rat study examined expression of 84 genes involved in neurotransmission after Selank administration.
Researchers found widespread changes in neurotransmission-related gene expression and concluded that one possible mechanism involves allosteric modulation of the GABAergic system.
Another laboratory study using human neuroblastoma cells found that Selank did not simply increase or decrease GABA-related genes on its own. Instead, it appeared to modify how cells responded to GABA and olanzapine, again suggesting more complicated modulation of GABA signaling.
So the most accurate description is:
Selank appears to modulate GABA-related signaling rather than functioning as a straightforward GABA agonist.
Does Selank Work Like Xanax?
Not exactly.
This comparison shows up constantly because both are associated with anxiety reduction.
But:
Xanax/alprazolam → benzodiazepine → directly enhances GABA-A receptor activity
while:
Selank → peptide → appears to influence GABAergic signaling through more complex mechanisms.
The clinical literature also doesn’t establish Selank as an equivalent replacement for alprazolam, diazepam, lorazepam, or other benzodiazepines.
Researchers have compared Selank with benzodiazepines, but those studies were relatively small.
So:
benzodiazepine comparison → legitimate research context
“natural Xanax without side effects” → unsupported marketing language.
What About Generalized Anxiety?
This is probably the strongest human research area for Selank.
The 62-patient study involving generalized anxiety disorder and neurasthenia found anxiolytic effects similar to medazepam.
Other Russian clinical work has also reported anxiolytic effects in anxiety-related conditions.
That means Selank has considerably more clinical evidence than compounds whose entire reputation comes from animal studies.
But there are important limitations:
- Small studies
- Limited replication
- Concentrated geographic research base
- Limited independent validation
- Little modern large-scale randomized evidence
- No U.S. approval
So it is fair to say:
Selank has preliminary human evidence for anxiety.
It is not fair to say:
Selank is a clinically established treatment for anxiety disorders worldwide.
What About Panic Attacks?
People frequently search for Selank in relation to:
panic attacks + panic disorder + acute anxiety.
That makes those useful discovery terms.
But there isn’t strong evidence demonstrating that Selank reliably stops panic attacks or is an established treatment for panic disorder.
Generalized anxiety research shouldn’t automatically be stretched to cover every anxiety disorder.
What About Social Anxiety?
Same issue.
Social anxiety involves different triggers and clinical patterns than generalized anxiety disorder.
Selank’s anxiolytic research makes social anxiety scientifically relevant.
But there is not strong condition-specific evidence showing Selank treats social anxiety disorder.
What About Stress?
Selank is heavily studied in the context of:
stress-related behavior and neurochemical responses.
Because anxiety, stress, GABA signaling, and neuroimmune responses overlap, researchers have investigated Selank as a possible regulator of stress-response systems.
That makes:
chronic stress + stress resilience + emotional stress + stress response
appropriate research categories.
But “stress resilience” should not be interpreted as:
proven prevention of stress-related illness.
What Are Enkephalins?
This is one of the less talked-about but interesting Selank mechanisms.
Enkephalins are naturally occurring opioid peptides produced by the body.
They participate in:
- Pain signaling
- Stress responses
- Reward
- Emotional regulation
One laboratory study found that Selank inhibited enzymes that break down enkephalins.
Researchers proposed that slowing enkephalin degradation could contribute to Selank’s anxiolytic effects.
That doesn’t mean Selank works like an opioid drug.
It means its effects may involve regulation of the body’s own peptide-signaling systems.
What About Memory?
Selank is often described as both:
anxiolytic + nootropic.
Animal studies have examined effects on learning and memory, and some clinical studies have described mild cognitive or antiasthenic effects.
That gives legitimate scientific context for:
- Memory
- Learning
- Attention
- Cognitive function
But there is not strong evidence showing Selank substantially improves memory in healthy humans.
What About Focus & Concentration?
These are among the most common modern search terms surrounding Selank.
People often describe effects such as:
- Better focus
- Less mental noise
- Improved concentration
- Better productivity
- More mental clarity
The scientific evidence is much thinner.
Selank does have neurological and cognitive research.
But controlled human trials have not established it as a treatment for:
ADHD + attention disorders + poor concentration + productivity problems.
Those belong in our keyword system because people research them—not because they are proven clinical effects.
What About Brain Fog?
“Brain fog” is a broad description rather than a medical diagnosis.
It can involve:
- Poor concentration
- Mental fatigue
- Memory problems
- Slowed thinking
Since Selank has been studied around cognition, anxiety, and neurotransmission, brain fog is a reasonable discovery topic.
There is not good evidence showing Selank specifically treats brain fog.
What About BDNF?
BDNF stands for:
Brain-Derived Neurotrophic Factor.
It is involved in:
- Neuron survival
- Synaptic plasticity
- Learning
- Memory
- Brain adaptation
BDNF is frequently mentioned in Selank discussions.
There is biological overlap between GABAergic signaling and BDNF pathways more generally, and Selank research has explored neurotrophic and gene-expression effects. However, it would be too strong to say that Selank has been clinically proven to “boost BDNF” in humans.
The more responsible version is:
Neurotrophic signaling is one area of Selank research, but a reliable human BDNF-enhancing effect has not been established.
What About Neuroplasticity?
Neuroplasticity refers to the nervous system’s ability to adapt and reorganize.
Processes involving:
BDNF + neurotransmitters + synaptic signaling + gene expression
all contribute.
Because Selank has shown effects on several of these systems in preclinical work, neuroplasticity is a reasonable research category.
But saying Selank:
“rewires your brain”
would dramatically overstate the evidence.
What About Depression?
Selank has mainly been studied as an anxiolytic rather than an antidepressant.
Anxiety and depression share some neurochemical pathways, and researchers have investigated Selank’s effects on:
- Serotonin-related systems
- Dopamine-related systems
- GABA signaling
- Stress responses
But there is not strong clinical evidence establishing Selank as a treatment for major depressive disorder.
So:
mood research → yes
established antidepressant → no.
What About PTSD?
PTSD involves:
fear processing + anxiety + stress pathways + memory + arousal systems.
Those overlap biologically with several Selank research areas.
But there isn’t strong clinical evidence establishing Selank as a PTSD treatment.
It’s appropriate as a search keyword, not a treatment claim.
What About ADHD?
Selank is commonly grouped with nootropics and is sometimes marketed for:
focus + attention + executive function.
That has led people to associate it with ADHD.
But there is no convincing clinical evidence establishing Selank as an ADHD medication.
ADHD belongs in the search system because someone researching attention peptides may encounter Selank.
The body copy should make clear that this doesn’t mean it treats ADHD.
What About Sleep?
This one is interesting because Selank is often described as calming without being heavily sedating.
That could theoretically affect sleep in people whose sleep problems are strongly linked to anxiety.
But there isn’t good evidence establishing Selank as a direct:
sleep medication + insomnia treatment + deep-sleep enhancer.
So if someone sleeps better because they feel calmer, that’s different from Selank being proven to directly improve sleep architecture.
Does Selank Make You Sleepy?
Selank’s research history is notable partly because researchers reported anxiolytic effects without the degree of sedation typically associated with benzodiazepines.
But individual effects may vary, and the controlled safety database is small.
It shouldn’t be described as guaranteed to be:
non-sedating + stimulating + calming
all at once.
What About the Immune System?
This is where Selank’s origin becomes important.
Remember:
Selank was developed from tuftsin-related research.
Tuftsin is an immune-regulatory peptide.
That means Selank has been investigated at the intersection of:
nervous system + immune system.
Researchers sometimes describe this as:
neuroimmune regulation.
This can include effects involving immune-cell signaling, inflammatory responses, and interactions between stress and immunity.
But again:
immunomodulation ≠ immune boosting.
Increasing immune activity isn’t always beneficial.
Some diseases result from immune systems that are already too active.
What About Inflammation?
Neuroimmune research naturally overlaps with inflammation.
Selank may influence inflammatory signaling in experimental settings.
But there isn’t enough evidence to call it an established anti-inflammatory treatment.
Conditions such as:
- Autoimmune disease
- Arthritis
- IBD
- Chronic inflammatory disorders
should not be presented as proven Selank indications.
What About Alcohol Withdrawal?
Selank has appeared in experimental research involving neurological stress and alcohol-related models.
That makes:
alcohol withdrawal + alcohol-related cognitive changes
reasonable research keywords.
But Selank is not an established treatment for alcohol withdrawal.
Alcohol withdrawal can be medically dangerous, so this distinction matters especially here.
Selank vs. N-Acetyl Selank Amidate
We just covered the modified analogue separately.
Selank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
This is the peptide actually used in the majority of published Selank research.
It has:
- Laboratory evidence
- Animal evidence
- Some human clinical research
- Anxiety studies
- GABA research
N-Acetyl Selank Amidate
Ac-Selank-NH₂
This is a modified analogue commonly found in today’s research market.
It has far less direct evidence.
So if a study says:
“Selank improved X”
that finding belongs to Selank unless the investigators specifically studied the modified analogue.
We should not automatically transfer it.
Selank vs. Semax
These two are frequently paired.
They are not the same peptide.
Selank
Research emphasis:
anxiety + stress + GABA + neuroimmune biology
Semax
Research emphasis:
neuroprotection + cognition + neurotrophic signaling + neurological injury
There is overlap involving:
- Brain function
- Cognition
- BDNF-related research
- Stress responses
But their origins and proposed mechanisms differ.
And there is no strong evidence proving that combining them produces special synergy.
Is Selank a Nootropic?
In the broad research-market sense:
yes, it is commonly categorized as one.
Scientifically, though, its strongest identity is probably:
experimental anxiolytic/neuroregulatory peptide.
Its cognitive research makes “nootropic” understandable, but that word can imply stronger healthy-person performance evidence than actually exists.
Evidence Snapshot
Laboratory Research: Yes
Animal Research: Yes
Human Clinical Research: Yes, but limited
Generalized Anxiety Research: Yes
GABA Research: Yes
Enkephalin Research: Yes
Cognition/Memory Research: Primarily preclinical with limited human signals
Stress Research: Yes
Neuroimmune Research: Yes
ADHD Evidence: Insufficient
Depression Evidence: Insufficient
PTSD Evidence: Insufficient
Large Modern Phase 3 Trials: No
FDA Approved: No
Overall Evidence: Selank has a legitimate scientific and limited human clinical record, especially around anxiety, but the evidence is far smaller and less independently replicated than that of approved anxiety medications.
What Do We Know?
We know Selank is a real experimental peptide with more than just anecdotal research behind it.
Human investigators have studied it in anxiety disorders, including a 62-patient comparison with medazepam.
Laboratory and animal studies also demonstrate real effects on:
GABA-related signaling + neurotransmission-related gene expression + enkephalin metabolism.
So its neurological research foundation is legitimate.
What Don’t We Know?
We don’t have strong evidence proving that Selank:
- Treats every anxiety disorder
- Stops panic attacks
- Treats social anxiety disorder
- Treats PTSD
- Treats depression
- Treats ADHD
- Eliminates brain fog
- Dramatically increases focus
- Improves intelligence
- Enhances memory in healthy people
- Prevents dementia
- Prevents Alzheimer’s disease
- Prevents Parkinson’s disease
- Reliably increases BDNF in humans
- Improves deep sleep
- Treats insomnia
- Treats autoimmune disease
- Treats alcohol withdrawal
- Produces benzodiazepine-level effectiveness without benzodiazepine-related risks
- Is safe for indefinite long-term use
The existing human evidence simply isn’t large enough to answer all of those questions.
What About Dependence & Withdrawal?
This is another place where marketing frequently gets ahead of the science.
Selank is sometimes advertised as:
“an anxiety peptide with no tolerance, dependence, or withdrawal.”
It has not demonstrated the classic dependence profile associated with benzodiazepines in the limited research available.
But absence of evidence isn’t the same as proving:
zero dependence risk + zero withdrawal risk + zero tolerance risk.
Large long-term human studies would be needed to establish that confidently.
What About Safety?
Published human studies provide some exposure experience with Selank.
But the overall human safety database remains relatively small.
FDA currently lists selank acetate (TP-7) among bulk substances that may present significant safety risks when used in compounding. FDA specifically notes possible immunogenicity related to aggregation and peptide impurities and says it lacks important information about safety issues from human administration.
That doesn’t mean FDA has proven Selank to be dangerously toxic.
It means FDA considers the available safety and product-characterization information inadequate for compounded use.
Research-market products add additional uncertainty involving:
purity + sterility + identity + concentration + degradation + manufacturing quality.
Research & Regulatory Status
Selank is not FDA approved.
FDA maintains Drugs@FDA as the authoritative database of approved U.S. drug products.
Selank does not have an FDA-approved drug indication in the United States.
FDA also specifically identifies selank acetate (TP-7) on its current list of bulk substances that may present significant safety risks in compounding, citing immunogenicity and impurity concerns along with inadequate safety information.
This is important because Selank’s use and research history outside the United States does not equal:
FDA approval + FDA-confirmed safety + FDA-confirmed efficacy.
Your Pep Resource Takeaway
Selank deserves a little more credit than many internet “brain peptides.”
It isn’t based entirely on:
seller descriptions + Reddit experiences + one mouse paper.
There is actual human research.
A small clinical study involving generalized anxiety and neurasthenia found anxiolytic effects similar to medazepam.
There is also legitimate laboratory and animal work involving:
GABAergic signaling + neurotransmitter gene expression + enkephalin metabolism.
But then the internet takes that real research and stretches it into:
anxiety + PTSD + ADHD + depression + memory + BDNF + brain fog + sleep + productivity + immunity + neuroprotection.
That’s where we need to separate interesting biology from established treatment effects.
The fairest 2026 description is:
Selank is a genuinely studied experimental anxiolytic peptide with limited human evidence and interesting neurochemical mechanisms—but it has not undergone the large, independent clinical development needed to establish it as a modern FDA-approved psychiatric medication.
Research Areas / Search Keywords
Selank, Selank peptide, Selank acetate, TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TKPRPGP, tuftsin, tuftsin analogue, anxiety, anxiety research, anxiety peptide, anxious feelings, generalized anxiety disorder, GAD, generalized anxiety, social anxiety research, social anxiety, panic research, panic disorder, panic attacks, chronic anxiety, stress, stress research, chronic stress, stress response, stress resilience, emotional stress, nervousness, calming peptide, relaxation research, mood, mood regulation, emotional regulation, depression research, low mood research, PTSD research, trauma research, fear response, GABA, gamma aminobutyric acid, GABAergic system, GABA-A receptor, GABAA, inhibitory neurotransmission, allosteric modulation, benzodiazepines, benzodiazepine alternative research, Xanax research, alprazolam, diazepam, Valium, medazepam, phenazepam, anxiety medication research, enkephalins, enkephalin metabolism, opioid peptides, endogenous opioids, stress peptides, brain health, neurological health, neuroscience, cognition, cognitive health, cognitive function, nootropic, nootropic peptide, memory, memory research, forgetfulness research, learning, learning research, focus, concentration, attention, ADHD research, executive function research, productivity research, mental performance, cognitive performance, mental clarity, brain fog, mental fatigue, burnout research, BDNF, brain-derived neurotrophic factor, neurotrophic factors, neuroplasticity, brain plasticity, synaptic plasticity, neuroprotection, neuroprotective peptides, neurotransmitters, neurotransmission, serotonin research, dopamine research, serotonergic signaling, dopaminergic signaling, hippocampus, prefrontal cortex, brain signaling, gene expression, neurological gene expression, sleep research, insomnia research, anxiety and sleep, deep sleep research, immune system research, neuroimmune signaling, immunomodulation, immune peptides, inflammation research, neuroinflammation, stress immune connection, alcohol research, alcohol withdrawal research, addiction research, alcohol and cognition, brain aging research, healthy brain aging, Alzheimer’s research, dementia research, Parkinson’s research, Selank vs Semax, Semax and Selank, Selank vs N-Acetyl Selank, N-Acetyl Selank Amidate, NA Selank, standard Selank, Russian peptides, Russian nootropics, experimental anxiety peptides, research peptides.
Educational Disclaimer: This profile is provided for educational and research-information purposes only. It is not medical advice and does not provide dosing, administration, psychiatric treatment, or purchasing recommendations. Selank has laboratory, animal, and limited human clinical research, particularly involving anxiety, but it is not FDA approved in the United States. FDA currently identifies selank acetate among bulk substances that may present significant safety risks in compounding because of potential immunogenicity, peptide-impurity concerns, and insufficient safety information.